CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

This was the stock's second consecutive day of losses.

Although CVS Health has underperformed its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

So, even beyond CVS Health's poor financial results, the guidance cuts are contributing to the terrible stock market performance the healthcare giant has posted in recent years.

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.

CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth reported Q3 results and cut its annual EPS outlook.

So, even beyond CVS Health's poor financial results, the guidance cuts are contributing to the terrible stock market performance the healthcare giant has posted in recent years.

So, even beyond CVS Health's poor financial results, the guidance cuts are contributing to the terrible stock market performance the healthcare giant has posted in recent years.

On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...